HealthTap is a Sunnyvale-based digital health company that connects patients with board-certified physicians 24/7 through video, phone, and text consultations. Founded in 2010, it operates a platform of 105,000 doctors across 141 specialties serving 23 million monthly members. The company pairs AI-powered symptom checking with live clinical consultations, offering affordable virtual primary and urgent care via subscription or per-visit pricing. Recent partnerships with Samsung Health, Eli Lilly's LillyDirect, and Commure signal a shift toward deep integration with major consumer and clinical platforms.
Hello Heart is a Menlo Park-based digital health company exclusively focused on cardiovascular health. Founded in 2013, it offers an AI-powered mobile app paired with a connected blood pressure monitor and smart pill box that helps members understand, track, and improve their heart health. Deployed through employers, health plans, and Medicare Advantage programs, Hello Heart has served users at 150+ Fortune 500 companies and government organizations. Independent peer-reviewed studies - including a JAMA study of 28,000+ participants - show that 84% of high-risk users reduced blood pressure over three years, with average medical cost savings exceeding $1,700 per enrolled member per year. The company has raised $148.5 million in total funding, most recently a $70 million Series D in May 2022.
Josh Rose is the CEO of Hawthorne Health, Inc. (formerly Hawthorne Effect), a Walnut Creek-based company building the largest community-based clinical trial site network in the U.S. A clinical research industry veteran with over 20 years of experience, Rose previously led decentralized clinical trial strategy at IQVIA and CVS Health before taking the helm at Hawthorne Health in early 2024. Under his leadership, Hawthorne has expanded to 75+ community locations, partnered with 40+ pharma sponsors, and pioneered a model that embeds certified clinical research staff inside independent pharmacies and patients' homes - bringing trials to communities that traditional research networks have long bypassed.
Maayan Cohen is the Co-Founder and CEO of Hello Heart, a Menlo Park-based digital therapeutics company focused exclusively on cardiovascular health. A former Israeli tank platoon commander turned strategy consultant, she built Hello Heart from a 2013 startup into a platform covering 1.6+ million members across Fortune 500 employers, backed by $148.5M in funding from investors including Khosla Ventures, IVP, and Stripes. Named to CNBC Changemakers 2024 and Inc. Female Founders 500 in 2025, Cohen is recognized for her empathy-driven leadership style - including managing her company from Tel Aviv bomb shelters during the 2023 Israel-Hamas war while providing housing and support for both Israeli and Palestinian staff.
David Foote is the Founder and CEO of zennya health, a mobile-first on-demand healthcare platform operating in the Philippines that delivers medical and wellness services to people's homes in under 30 minutes. A serial entrepreneur with 25+ years building technology companies, Foote came to the Philippines for scuba diving and stayed to build a virtual hospital infrastructure that has completed over 600,000 services. Based between San Francisco and Manila, he leads a company of 110 employees with ~$31.3M in annual revenue backed by $1.2M in seed funding.